Adjuvant Chemotherapy for High Malignant Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
- Status
- RECRUITING
- Phase
- PHASE2
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3
An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting
- Status
- RECRUITING
- Phase
- PHASE2
A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
- Status
- RECRUITING
- Phase
- PHASE3
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- Status
- RECRUITING
- Phase
- PHASE3
Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
- Status
- RECRUITING
- Phase
- PHASE3
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2